Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets Proceedings of a Symposium (2018) / Chapter Skim
Currently Skimming:
7 Molybdenum-99 Supply Sustainability
7 Molybdenum-99 Supply Sustainability
Pages 43-46
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 43... ...
International organizations such as the Organisation for Economic Co-operation and Development's Nuclear Energy Agency (OECD-NEA) have recognized that as medical isotope production is progressively becoming a larger part of reactors' workloads, the historic pattern of government subsidization has proven to lead to Mo-99 market sustainability issues.
|
From page 44... ...
. The purpose of the Joint Declaration was to "provide a more formal and coordinated political commitment by governments of the countries participating in the HLG-MR that would foster the necessary changes needed across the supply chain, both in producing and user countries." Information for OECD-NEA's review on implementation of FCR is obtained through self-assessments from Lack of new Potential investments future shortage Low prices Government intervention (subsidies)
|
From page 45... ...
The 14 countries that adhere to the declaration state that: WE COMMIT, with the aim of jointly promoting an internationally consistent approach to ensuring the long‐term secure supply of medical radioisotopes, to implement the HLG‐MR principles in a timely and effective manner, and to: • Take co‐ordinated steps, within our countries' powers, to ensure that 99Mo or 99mTc producers and, where applicable, generator manufacturers in our countries implement a verifiable process for introducing full‐cost recovery at all facilities that are part of the global supply chain for 99mTc; • Encourage the necessary actions undertaken by 99Mo processing facilities or 99mTc producers in our countries to ensure availability of reserve capacity capable of replacing the largest supplier of irradiated targets in their respective supply chain; • Take the necessary actions to facilitate the availability of 99mTc, produced on an economically sus tainable basis, as outlined in the HLG‐MR principles; • Encourage all countries involved in any aspect of the 99mTc supply chain, and that are not party to the present Joint Declaration, to take the same approach in a co‐ordinated manner; • Take the necessary actions described above by the end of December 2014 or as soon as technically and contractually feasible thereafter, aware of the need for early action to avoid potential shortages of medical radioisotopes that could arise from 2016; • Report on an annual basis to the OECD Nuclear Energy Agency (NEA) on the progress made at the national level and support an annual review of the progress made at the international level, both in light of this Joint Declaration.
|
From page 46... ...
agreed that implementation of FCR for the aqueous homogeneous reactor project that involves construction of a new production facility is essential. • Implementation of FCR for projects that involve construction of new reactors differed based on whether the reactor to be constructed will be dedicated to medical isotope production or is also intended for research activities.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.